About us
Diederik Engbersen, MSc
CEO
“CimCure’s immunotherapy is broadly applicable”
Diederik holds an MSc degree in medicine from Leiden University, and has more than 25 years of experience in the life science industry. He has held holding various international and executive positions in strategic marketing, R&D, business development and general management in both established, as well as early stage and start up companies.
Prof. Arjan Griffioen, PhD
CSO
“Stick to your goals and never give up”
Arjan holds a PhD in medicine from Utrecht University. He is a key opinion leader in the field of angiogenesis, was trained as an immunologist and has published >280 peer-reviewed scientific publications. He heads the Angiogenesis Laboratory, is director of the Graduate School of Oncology (OOA) and is founder and Editor-in-Chief of the journal Angiogenesis.
Else Huijbers, PhD
Senior Scientist
“Life is what you make of it”
Else holds a PhD in medicine from Uppsala University, Sweden. She was trained as a pharmacist and has received several major grants from national and European sources. She presented the first proof-of-concept for using conjugate vaccines against the tumour vasculature.
Gerard Spanbroek,
Advisor
“CimCure will make a difference for cancer patients”
Gerard has more than 30 years of (international) working experience in the field of finance and building companies. He was active for ING Group for 20 years before switching to public fund management of startup companies. Building companies in combination with finance is his greatest passion (besides sport). Gerard studied business economics and holds masters’ degrees in real estate development & investment and management & organization.
Raymond Perrenet, COO
“Always try shooting for the moon, if you miss you land between the stars”
Raymond has more than 25 years of international working experience. He has held several management board positions in large corporate organizations such as T-Mobile / Deutsche Telekom ranging from corporate finance to strategy and as director marketing to consumers. After switching to more entrepreneur-led companies, he has utilized his expertise and experience in managing and scaling companies. He holds a degree in computer science.
Joost van Bree, CMO
“‘Nunc aut nunquam’ (‘now or never’)“
Joost obtained an MSc and PharmD from Leiden University, after which did a Ph.D. in Clinical Pharmacology. From 1995 onwards he has worked in senior management and C-suite positions with several public and private life science companies such as Sandoz/Novartis, Teva, Pharming, Noviogendix, Pepscan, HealthWise Investment Group and Immunovo.
Marijke Vendrig, QA/QP
“Enjoy and join the beautiful things in life“
Marijke holds a MSc in Medical Biology from Utrecht University and has more than 30 years experience in the biotechnology industry. She gained her knowledge about Quality Assurance and biotechnology manufacturing and testing at producers and developers for both veterinary and human vaccines. As Qualified Person she will safeguard that CimCure products meet the regular expectations and are safe for patients.
Quinty Hansen, Research technician
“With hard work and dedication, anything is possible”
Quinty graduated from the Master Oncology program at Amsterdam UMC in 2022. She completed her graduation thesis at the Princess Máxima Center, with a focus on organoid models and the Wnt pathway.
Emma Bos, Research technician
“Make a difference”
Emma holds a Bachelor of Science degree in Biology and Medical Laboratory Research from the University of Applied Sciences in Leiden and has worked as a Research Technician for four years. In her previous position at the Amsterdam UMC Department of Medical Oncology, Emma acquired practical experience in mapping the tumor immune microenvironment of gastric and esophageal cancers, as well as in developing patient-derived organoid models. She will now be working on the development of tumor vaccinations using the iBoost technology from CimCure, contributing to innovative approaches in cancer immunotherapy.
Scientific Advisory Board
Prof. Kees Melief
Kees is a Dutch immunologuist specialising in cancer immunology and immunotherapy, with a focus on therapeutic cancer vaccines. He is emeritus Professor, former head of the Department of Immunohematology and Blood Transfusion at the Leiden University Medical Center and Chief Scientific Officer at ISA Therapeutics in Netherlands. He is known for his work in the field of cancer immunology, devising new cancer therapies based on the activation of the patient’s own immune system.
Prof. Patrycja Nowak-Sliwinska
Patrycja is an expert in vascular biology and cancer and co-inventor of CimCure’s Technology. Her current expertise is in the design of combination therapies for the treatment of cancer. She is Professor of Molecular Pharmacology at the School of Pharmaceutical Sciences at the University of Geneva, Switzerland. She leads the Cancer Systems Pharmacology Group, a multidisciplinary research team dedicated to understanding and optimizing therapeutic strategies for cancer using systems pharmacology approaches.
Partners
